Proteintech Genomics Launches First Commercially Available Solution for the Detection of Intracellular Proteins for Single-Cell RNAseq Experiments

Contributed by: Business Wire

Logo

Images

Proteintech Genomics' MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail containing 53 antibodies against intracellular and cell surface proteins, plus 5 isotype controls (Photo: Business Wire)

Proteintech Genomics' MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail containing 53 antibodies against intracellular and cell surface proteins, plus 5 isotype controls (Photo: Business Wire)

Business Wire embedded0

Tags

Biotechnology

Manufacturing

Other Health

Health

General Health

Other Science

Medical Devices

Research

Other Manufacturing

Genetics

Science

Proteintech Genomics

More Like This

Proteintech celebrates the opening with a ribbon cutting event. Pictured: Dr. Jason Li, CEO of Proteintech, along with Proteintech executives and local government officials. (Photo: Business Wire)

Proteintech Germany triples its space with a new office and laboratory

Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress

PROTEINA Co., Ltd. Announces Breakthrough Research Published in Nature Biomedical Engineering

PR Newswire associated0

Sengenics Corporation Unveils i-Ome® Cancer: A Breakthrough in Cancer Precision Medicine

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies

Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine Biosciences

(Graphic: Business Wire)

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development

Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement